Clinical and research tests for C2750067 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 31

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
SERPINE1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Blood Coagulation Panel Centogene AG - the Rare Disease Company Germany	110	112	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Plasminogen activator inhibitor-1 deficiency, 613329, Autosomal recessive, Autosomal dominant (Congenital plasminogen activator inhibitor type 1 deficiency) (SERPINE1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Transcription of plasminogen activator inhibitor, modulator of (Congenital plasminogen activator inhibitor type 1 deficiency) (SERPINE1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Bleeding Disorders Panel PreventionGenetics, part of Exact Sciences United States	78	79	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Coagulation Factor Deficiency Panel PreventionGenetics, part of Exact Sciences United States	21	20	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Quest Diagnostics Nichols Institute San Juan Capistrano United States	1	1	T Targeted variant analysis
Plasminogen activator inhibitor-1 deficiency (sequence analysis of SERPINE1 gene) CGC Genetics Unilabs Portugal	1	1	C Sequence analysis of the entire coding region
Plasminogen Activator Inhibitor 1 Polymorphism Duzen Laboratories Duzen BBAGUAS Turkey	1	1	T Targeted variant analysis
PAI-1 DNA analysis - 4G / 5G Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey	1	1	C Sequence analysis of the entire coding region
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States	80	66	D Deletion/duplication analysis C Sequence analysis of the entire coding region
SERPINE1 - Genetic Analysis Versiti Diagnostic Laboratories Versiti, Inc United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
PAI 4G/5G POLYMORPHISM BioReference Health United States	1	1	T Targeted variant analysis
Factor II (Prothrombin) G20210A Genotyping, Factor V Leiden Genotyping, SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	4	3	T Targeted variant analysis
Factor V Leiden Genotyping, MTHFR C677T and A1298C Genotyping, and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	4	3	T Targeted variant analysis
Factor V Leiden Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	2	2	T Targeted variant analysis
MTHFR C677T and A1298C Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	3	2	T Targeted variant analysis
Factor II (Prothrombin) G20210A Genotyping, Factor V Leiden Genotyping, MTHFR C677T and A1298C Genotyping, SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	6	4	T Targeted variant analysis
Factor II (Prothrombin) G20210A Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States	4	2	T Targeted variant analysis
Coagulation Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States	25	20	D Deletion/duplication analysis S Mutation scanning of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.